MILLENNIUM MANAGEMENT LLC
Q4 2020 13F-HR Holdings
Net value change ($000)
+57,272,433
(70.5%)
New positions
1060
Sold out positions
585
Turnover %
10.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SPY | 2,894,231 | 1049.8% |
| AAPL | 2,214,308 | 1094.2% |
| MSFT | 1,488,159 | 449.3% |
| AMZN | 957,919 | 226.4% |
| BABA | 839,334 | 701.7% |
| META | 826,254 | 260.7% |
| INTC | 819,008 | 1173.0% |
| NVDA | 801,549 | 899.8% |
| IWM | 496,429 | 2759.6% |
| GOOGL | 479,437 | 300.6% |
Top Reduces (Value $000, Stocks/ETFs)
| MOMENTA PHARMACEUTICALS INC | -260,616 | -100.0% |
| TD AMERITRADE HOLDING CORP | -240,790 | -100.0% |
| IMMUNOMEDICS INC | -233,896 | -100.0% |
| KDP | -161,060 | -98.8% |
| ORCL | -136,447 | -78.2% |
| FDX | -134,664 | -76.0% |
| LIN | -122,763 | -69.1% |
| HOLX | -120,471 | -92.9% |
| Foley Trasimene Acquisition II | -106,082 | -99.0% |
| Wright Medical Group N.V. | -103,389 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
60,782,369
(43.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|